/
DYAI
$0.80-$0.11 (-12.49%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$32.1M
36M shares
52-week range
$0.65 – $1.60
15% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-4.50
Dyadic International, Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.
www.dyadic.com- Employees
- 5
- IPO / List date
- Nov 5, 2004
- HQ
- JUPITER, FL
Held by traders on TradeandTell
No one on the platform currently holds DYAI.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 81,665 | $67.0K |
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded DYAI yet.
